Implantable Defibrillator Models May Fail to Deliver Shock Therapy
Medtronic implantable cardiac defibrillators may fail to deliver electrical therapy during treatment due to a defective feedthrough component. Approximately 1,878 devices are affected.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA classified this as Class I, indicating potential for serious harm. The hazard is failure to deliver life-saving defibrillation therapy when needed. No serious injuries or deaths have been reported in the source text.
Plain-English summary
Medtronic cardiac defibrillator models COBALT HF QUAD MRI IS4 DF1 (Model DTPB2Q1) are subject to recall due to a potential malfunction in energy delivery. These implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) may deliver reduced or no energy output during high-voltage therapy. Approximately 1,878 units have been distributed in the United States and worldwide.
The defect involves a specific glassed feedthrough component used in these devices. In rare cases, this component may not function properly, resulting in reduced or complete loss of electrical energy output when the device attempts to deliver defibrillation therapy. This malfunction could prevent the device from treating dangerous heart rhythms when treatment is needed.
Patients who have received one of these devices should contact their cardiologist or healthcare provider to determine if their device is affected. Discuss with your healthcare provider whether replacement or other management is appropriate. Do not discontinue any prescribed medications or alter normal activities without consulting your healthcare provider.
The recalled product
- Product
- CRTD COBALT HF QUAD MRI IS4 DF1, Model Number DTPB2Q1 ; Implantable Cardioverter Defibrillators
- Affected units
- 1,878
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- GTIN 00763000178185
- Lot Serial Numbers: RTL600234S
- RTL600470S
- RTL601046S
- RTL601412S
- RTL601722S
- RTL601669S
- RTL601698S
- RTL600323S
- RTL600660S
- RTL600661S
- RTL601185S
- RTL601206S
- RTL601213S
- RTL601406S
- RTL601445S
- RTL601446S
- RTL600649S
- RTL600650S
- RTL601428S
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 120 recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 120 products in this recall →Related recalls
Same manufacturer · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
See all →- CriticalMedtronic CRT-D Defibrillators: Rare Energy Output Failure Risk During Therapy
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillators Recalled for Reduced Therapy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Defibrillators Recalled for Potential Therapy Delivery Failure
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators at Risk of Reduced Energy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillator may lose energy output during therapy
FDA (Devices) · 2023-06-28
Same hazard · energy output failure
See all →- SevereMedtronic CRT-D and ICD Defibrillators Recalled for Potential Therapy Output Failure
FDA (Devices) · 2023-06-28
- SevereImplantable Defibrillators Risk Therapy Failure Due to Feedthrough Defect
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators Recalled for Potential High Voltage Therapy Failure
FDA (Devices) · 2023-06-28
- SevereImplantable defibrillators risk energy output failure during high voltage therapy
FDA (Devices) · 2023-06-28
- SevereImplantable Defibrillators Recalled for Rare Risk of Energy Output Failure
FDA (Devices) · 2023-06-28